IL17A and colorectal carcinoma: Toward resolving these paradoxes, elegant mouse molecular genetic experiments demonstrated that TCRγδ+ IEL, including BTNL-selected NKp46+ cells protected against early stages of CRC, whereas if such control was evaded, invasive CRC growth was enhanced by IL-17-producing γδ cells(113).